Document is current
Any future updates will be listed below
-
Authors
Bonafide, Christopher P. https://orcid.org/0000-0003-2823-5883
Xiao, Rui
Schondelmeyer, Amanda C.
Pettit, Amy R.
Brady, Patrick W. https://orcid.org/0000-0002-7078-3077
Landrigan, Christopher P.
Wolk, Courtney Benjamin https://orcid.org/0000-0001-9542-2801
Cidav, Zuleyha https://orcid.org/0000-0003-4323-0175
Ruppel, Halley
Muthu, Naveen
Williams, Nathaniel J. https://orcid.org/0000-0002-3948-7480
Schisterman, Enrique
Brent, Canita R.
Albanowski, Kimberly
Beidas, Rinad S. https://orcid.org/0000-0001-6056-6071
,
Rajbhandari, Prabi
Knuth, Emily
Bailey, Michelle
Lucey, Kate
Stoeck, Patty
House, Samantha
Silver, Alyssa
Naifeh, Monique
Tchou, Michael
Tyler, Amy
Lee, Vivian
Cummings, Erin
Lee, Clifton
Shomaker, Kyrie
Mihalek, Alexandra
Solomon, Courtney
Parlar-Chun, Raymond
Berg, Kathleen
Ryan, Nick
Halley, Tina
Orr, Mary
Liljestrom, Tracey
Preloger, Erin
Parthasarathy, Padmavathy
Shakir, Rashida
Chu, Andrew
Greenfield, Morgan
Prasto, Julianne
Le, Ann
Monroe, Kimberly
Lauffer, Andrea
Carter, Meredith
Halmon, Kamilah
Huff, Glen
Patel, Kiran Gadani
Ono, Jennie
Schroeder, Alan
Plemmons, Gregory
Perry, Michael
Banker, Sumeet
Lee, Jennifer
Willer, Robert
Lee, Begem
Rhee, Kyung
Baker, Richelle
Gregory, Polina Frolova
Parikh, Vipul
Wallace, Mini
Edwards, Stephen
Beckner, Lisa
Hamline, Michelle
Solan, Lauren
Cioffredi, Leigh-Anne
Johnson, Scarlett
Andrake, John
Webb, Nicole
Berkwitt, Adam
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (U01HL159880)
- License Information
-
More Information
Article History
Received: 26 July 2022
Accepted: 10 October 2022
First Online: 21 October 2022
Declarations
:
: This study was approved by the Institutional Review Board (IRB) at Children’s Hospital of Philadelphia (FWA00000459) on July 23, 2021. Prior to study commencement at each participating site, each US site established an IRB reliance agreement with Children’s Hospital of Philadelphia’s IRB using an electronic reliance platform. The Canadian site obtained local Research Ethics Board (REB) approval independently. Due to a number of challenges posed by the pandemic, including but not limited to staffing challenges and low bronchiolitis patient volumes, we amended the protocol to improve the feasibility for participating sites. In order to provide the most up-to-date protocol for publication, this manuscript represents the fourth scientific amendment, including recommendations from our Data and Safety Monitoring Board, protocol version date May 20, 2022, approved by the IRB on June 20, 2022. All amendment letters describing each change are automatically forwarded to relying sites via the electronic IRB system. For patients who are the subjects of data collection, the IRB granted a waiver of consent/parental permission per 45 CFR 46.116(f)(3), a waiver of assent per 45 CFR 46.408(a), and a waiver of HIPAA authorization per 45 CFR 164.512(i)(2)(ii). For staff who are the subjects of questionnaires and qualitative interviews, the IRB granted a waiver of documentation of consent under 45 CFR 46.117(c)(1)(ii). For parents/guardians who are the subjects of qualitative interviews, the IRB granted a waiver of documentation of consent under 45 CFR 46.117(c)(1)(ii) and an alteration of HIPAA authorization (to obtain verbal authorization) under 45 CFR 164.512(i)(2)(ii).
: Not applicable.
: RSB is an Associate Editor of <i>Implementation Science</i>; all decisions on this paper were made by other editors. RSB is the principal at Implementation Science & Practice, LLC. She receives royalties from Oxford University Press, consulting fees from United Behavioral Health and OptumLabs, and serves on the advisory boards for Optum Behavioral Health, AIM Youth Mental Health Foundation, and the Klingenstein Third Generation Foundation, outside of the submitted work. The other authors declare that they have no competing interests.
